Company intelligence / Profile preview

Flomics Biotech

Barcelona, Catalonia, Spainflomics.com ↗

Ownership: Private
Employees: ~25
Development stage: Preclinical

Overview

Flomics Biotech has developed a novel liquid biopsy test based on cell-free RNA profiling from blood samples, using next-generation sequencing combined with machine learning to enable early detection of multiple cancers and other complex diseases. Their technology aims to provide minimally invasive screening before symptoms appear. They also offer tailored biomarker panels, bioinformatics services, and a cloud-based NGS analysis solution that was deployed during the COVID‑19 pandemic. The company’s main products are currently at the preclinical/prototype-ready stage.

Therapeutic areas: OncologyRare DiseasesHematologyNeurologyInfectious Diseases
Modalities: Liquid biopsy (cfRNA-based)Biomarker panelsNext-generation sequencing (NGS)Machine learning/AI-driven diagnostics
Industry: Molecular Diagnostics

Partnerships

Collaborations with hospitals worldwide for validation studies; specific partners not named but active in global hospital collaborations.

Beyond the preview

Go deeper on Flomics Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flomics Biotech.

Explore the full profile